Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,085
archived clinical trials in
Cervical Cancer

Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project (Prevention Care Manager 3 Project)
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project
Status: Enrolling
Updated:  7/25/2016
Urban Health Plan
483
mi
from 43215
Bronx, NY
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project (Prevention Care Manager 3 Project)
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project
Status: Enrolling
Updated: 7/25/2016
Urban Health Plan
483
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project (Prevention Care Manager 3 Project)
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project
Status: Enrolling
Updated:  7/25/2016
Montefiore Family Care Center
485
mi
from 43215
Bronx, NY
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project (Prevention Care Manager 3 Project)
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project
Status: Enrolling
Updated: 7/25/2016
Montefiore Family Care Center
485
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project (Prevention Care Manager 3 Project)
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project
Status: Enrolling
Updated:  7/25/2016
Good Shepherd Service
483
mi
from 43215
Bronx, NY
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project (Prevention Care Manager 3 Project)
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project
Status: Enrolling
Updated: 7/25/2016
Good Shepherd Service
483
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
1662
mi
from 43215
Phoenix, AZ
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
166
mi
from 43215
Indianapolis, IN
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
188
mi
from 43215
Louisville, KY
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
188
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
344
mi
from 43215
Baltimore, MD
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
643
mi
from 43215
Boston, MA
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
481
mi
from 43215
New York, NY
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
1513
mi
from 43215
Salt Lake City, UT
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
1513
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
2005
mi
from 43215
Seattle, WA
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
2005
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
335
mi
from 43215
Milwaukee, WI
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
335
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
1963
mi
from 43215
Newport Beach, CA
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
1963
mi
from 43215
Newport Beach, CA
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
1959
mi
from 43215
Orange, CA
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
1959
mi
from 43215
Orange, CA
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
2100
mi
from 43215
Palo Alto, CA
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
2100
mi
from 43215
Palo Alto, CA
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
2107
mi
from 43215
San Francisco, CA
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
2107
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
1162
mi
from 43215
Denver, CO
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
1162
mi
from 43215
Denver, CO
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
537
mi
from 43215
New Haven, CT
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
955
mi
from 43215
Boca Raton, FL
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
955
mi
from 43215
Boca Raton, FL
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
792
mi
from 43215
Orlando, FL
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
792
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
931
mi
from 43215
West Palm Beach, FL
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
931
mi
from 43215
West Palm Beach, FL
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
285
mi
from 43215
Hinsdale, IL
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
285
mi
from 43215
Hinsdale, IL
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
699
mi
from 43215
Scarborough, ME
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
699
mi
from 43215
Scarborough, ME
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
425
mi
from 43215
Voorhees, NJ
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
425
mi
from 43215
Voorhees, NJ
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
354
mi
from 43215
Durham, NC
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
354
mi
from 43215
Durham, NC
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
306
mi
from 43215
Winston-Salem, NC
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
849
mi
from 43215
Oklahoma City, OK
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
417
mi
from 43215
Abington, PA
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
417
mi
from 43215
Abington, PA
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
162
mi
from 43215
Pittsburgh, PA
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
162
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Immediate Vaginal Reconstruction After Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function
Immediate Vaginal Reconstruction Following Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function
Status: Enrolling
Updated:  8/9/2016
Memorial Sloan Kettering Cancer Center
480
mi
from 43215
New York, NY
Immediate Vaginal Reconstruction After Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function
Immediate Vaginal Reconstruction Following Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function
Status: Enrolling
Updated: 8/9/2016
Memorial Sloan Kettering Cancer Center
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV
Status: Enrolling
Updated:  11/29/2016
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
416
mi
from 43215
Philadelphia, PA
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV
Status: Enrolling
Updated: 11/29/2016
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV
Status: Enrolling
Updated:  11/29/2016
Fox Chase Cancer Center - Philadelphia
420
mi
from 43215
Philadelphia, PA
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV
Status: Enrolling
Updated: 11/29/2016
Fox Chase Cancer Center - Philadelphia
420
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
High-dose Periop Statins for Prevention of DVT
High-dose Statin Therapy in the Perioperative Period and DVT Prevention.
Status: Enrolling
Updated:  11/30/2016
Yale-New Haven Hospital
537
mi
from 43215
New Haven, CT
High-dose Periop Statins for Prevention of DVT
High-dose Statin Therapy in the Perioperative Period and DVT Prevention.
Status: Enrolling
Updated: 11/30/2016
Yale-New Haven Hospital
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Pillars4Life Trial
Pillars4Life Randomized Control Trial
Status: Enrolling
Updated:  12/6/2016
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Pillars4Life Trial
Pillars4Life Randomized Control Trial
Status: Enrolling
Updated: 12/6/2016
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
Status: Enrolling
Updated:  12/14/2016
University of Texas M.D. Anderson Cancer Center
995
mi
from 43215
Houston, TX
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
Status: Enrolling
Updated: 12/14/2016
University of Texas M.D. Anderson Cancer Center
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
Status: Enrolling
Updated:  12/14/2016
Lyndon B. Johnson General Hospital
988
mi
from 43215
Houston, TX
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
Status: Enrolling
Updated: 12/14/2016
Lyndon B. Johnson General Hospital
988
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery
A Phase I Study Using Abdominal Radiotherapy as a Cisplatin Chemosensitizer for Optimally Debulked Stage III/IV Carcinoma of the Endometrium
Status: Enrolling
Updated:  12/14/2016
University of Miami Sylvester Comprehensive Cancer Center - Miami
992
mi
from 43215
Miami, FL
Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery
A Phase I Study Using Abdominal Radiotherapy as a Cisplatin Chemosensitizer for Optimally Debulked Stage III/IV Carcinoma of the Endometrium
Status: Enrolling
Updated: 12/14/2016
University of Miami Sylvester Comprehensive Cancer Center - Miami
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer
A Phase I/II Study of Docetaxel as a Radiosensitizer for Locally Advanced Cervical Cancer (GIA 13026)
Status: Enrolling
Updated:  12/14/2016
University of Miami, Sylvester Comprehensive Cancer Center
996
mi
from 43215
Miami, FL
Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer
A Phase I/II Study of Docetaxel as a Radiosensitizer for Locally Advanced Cervical Cancer (GIA 13026)
Status: Enrolling
Updated: 12/14/2016
University of Miami, Sylvester Comprehensive Cancer Center
996
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Internet-based System for Cancer Patients to Self-report Toxicity
Pilot Study of STAR, an Internet-based System for Cancer Patients to Self-report Toxicity Symptoms, Performance Status, and Quality of Life
Status: Enrolling
Updated:  1/9/2017
Memorial Sloan Kettering Cancer Center
480
mi
from 43215
New York, NY
Internet-based System for Cancer Patients to Self-report Toxicity
Pilot Study of STAR, an Internet-based System for Cancer Patients to Self-report Toxicity Symptoms, Performance Status, and Quality of Life
Status: Enrolling
Updated: 1/9/2017
Memorial Sloan Kettering Cancer Center
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic
Phase I Study of Dasatinib in Combination With Ipilimumab for Patients With Advanced Gastrointestinal Stromal Tumor and Other Sarcomas
Status: Enrolling
Updated:  1/9/2017
Memorial Sloan Kettering Cancer Center
480
mi
from 43215
New York, NY
Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic
Phase I Study of Dasatinib in Combination With Ipilimumab for Patients With Advanced Gastrointestinal Stromal Tumor and Other Sarcomas
Status: Enrolling
Updated: 1/9/2017
Memorial Sloan Kettering Cancer Center
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Zinc Supplements in Lowering Cadmium Levels in Smokers
Do Dietary Supplements of Zinc Reduce Serum Cadmium Levels in Smokers?
Status: Enrolling
Updated:  1/18/2017
Wake Forest University Comprehensive Cancer Center
306
mi
from 43215
Winston-Salem, NC
Zinc Supplements in Lowering Cadmium Levels in Smokers
Do Dietary Supplements of Zinc Reduce Serum Cadmium Levels in Smokers?
Status: Enrolling
Updated: 1/18/2017
Wake Forest University Comprehensive Cancer Center
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
[18F] Flourothymidine (FLT) PET/CT Imaging for Gynecologic Cancers
[18F] Flourothymidine (FLT) PET/CT Imaging for Gynecologic Cancers
Status: Enrolling
Updated:  1/23/2017
Abramson Cancer Center of the University of Pennsylvania
414
mi
from 43215
Philadelphia, PA
[18F] Flourothymidine (FLT) PET/CT Imaging for Gynecologic Cancers
[18F] Flourothymidine (FLT) PET/CT Imaging for Gynecologic Cancers
Status: Enrolling
Updated: 1/23/2017
Abramson Cancer Center of the University of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
Status: Enrolling
Updated:  2/9/2017
Masonic Cancer Center at University of Minnesota
624
mi
from 43215
Minneapolis, MN
Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
Status: Enrolling
Updated: 2/9/2017
Masonic Cancer Center at University of Minnesota
624
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated:  3/9/2017
DCSNO Carrollton Medical Center
798
mi
from 43215
New Orleans, LA
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated: 3/9/2017
DCSNO Carrollton Medical Center
798
mi
from 43215
New Orleans, LA
Click here to add this to my saved trials
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated:  3/9/2017
DCSNO St Cecelia Medical Center
798
mi
from 43215
New Orleans, LA
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated: 3/9/2017
DCSNO St Cecelia Medical Center
798
mi
from 43215
New Orleans, LA
Click here to add this to my saved trials
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated:  3/9/2017
EXCELth - Ida Hymel Community Health Center
798
mi
from 43215
New Orleans, LA
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated: 3/9/2017
EXCELth - Ida Hymel Community Health Center
798
mi
from 43215
New Orleans, LA
Click here to add this to my saved trials
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated:  3/9/2017
Tulane Communty Health Center at Covenant House
798
mi
from 43215
New Orleans, LA
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated: 3/9/2017
Tulane Communty Health Center at Covenant House
798
mi
from 43215
New Orleans, LA
Click here to add this to my saved trials
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated:  3/9/2017
Tulane Faculty Practice
798
mi
from 43215
New Orleans, LA
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated: 3/9/2017
Tulane Faculty Practice
798
mi
from 43215
New Orleans, LA
Click here to add this to my saved trials
Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix
A Phase III Randomized Study of Pretherapeutic Para-aortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Dispositioned to Definitive Chemoradiotherapy
Status: Enrolling
Updated:  3/21/2017
Lyndon B. Johnson General Hospital
988
mi
from 43215
Houston, TX
Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix
A Phase III Randomized Study of Pretherapeutic Para-aortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Dispositioned to Definitive Chemoradiotherapy
Status: Enrolling
Updated: 3/21/2017
Lyndon B. Johnson General Hospital
988
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix
A Phase III Randomized Study of Pretherapeutic Para-aortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Dispositioned to Definitive Chemoradiotherapy
Status: Enrolling
Updated:  3/21/2017
University of Texas M.D. Anderson Cancer Center
995
mi
from 43215
Houston, TX
Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix
A Phase III Randomized Study of Pretherapeutic Para-aortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Dispositioned to Definitive Chemoradiotherapy
Status: Enrolling
Updated: 3/21/2017
University of Texas M.D. Anderson Cancer Center
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials